Robert Müller

Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.